IRIX
IRIDEX CORP
Key Financials
Revenue
$52.7M
↑ 8.2%
Net Income
$-4437000
↑ 50.2%
Operating Income
$-2571000
↑ 69.0%
Gross Profit
$19.2M
↓ 1.4%
EPS (Diluted)
$-0.26
↑ 51.9%
Total Liabilities
$24.2M
↓ 10.4%
Shareholders' Equity
$4.9M
↑ 134.7%
Total Assets
$29.2M
↑ 0.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/18/2026 | View on SEC |
| 8-K | 8/18/2026 | View on SEC |
| 8-K | 7/16/2026 | View on SEC |
| 4 | 7/14/2026 | View on SEC |
| 4 | 7/14/2026 | View on SEC |
| SCHEDULE 13D/A | 7/13/2026 | View on SEC |
| 4 | 7/8/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IRIX |
| Company Name | IRIDEX CORP |
| CIK | 1006045 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0103 |
| State of Incorporation | DE |
| Phone | 6509404700 |